What Babies' Immune Systems at Birth Might Tell Us About Type 1 Diabetes Risk
A new study examined immune signatures in newborns and their mothers to understand what early markers might be linked to later Type 1 diabetes development. Researchers found patterns of inflammation that could offer clues about disease onset.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Mothers of children who later developed Type 1 diabetes had distinct immune protein patterns at delivery, with 60 maternal proteins differing significantly from control groups.
- Newborns who went on to develop Type 1 diabetes showed changes in immune and inflammatory pathways, though fewer proteins were affected than in mothers.
- Both maternal and newborn immune profiles pointed to shared inflammatory and immune signaling patterns—not to infection with a specific virus.
- DNA methylation changes in cord blood were modest but aligned with immune-related genes, supporting a connection between early immune programming and later diabetes development.
Understanding Immune Clues Before Diagnosis
Type 1 diabetes develops over time, often with no symptoms until significant damage has occurred. Researchers are working to identify early warning signs—biological markers that might appear before a child is diagnosed. A new study published in Cells looked at immune signatures in newborns and their mothers to see if measurable differences at birth could be linked to children who later developed Type 1 diabetes.
The research used data from the ABIS birth cohort, examining immune proteins (measured through proteomics) and DNA methylation patterns in cord blood. These biological markers may reflect how the immune system was programmed before birth and how it responds in the first moments of life.
What Researchers Found in Mothers and Newborns
When comparing mothers who had children that later developed Type 1 diabetes to mothers in a control group, researchers found significant differences in maternal immune protein signatures at delivery. Sixty maternal proteins differed between the two groups after statistical corrections were applied.
In newborns, the picture was different. Only three proteins differed significantly between babies who would later develop Type 1 diabetes and those who would not. However, both maternal and neonatal samples showed enrichment in immune and inflammatory pathways, suggesting that inflammation may play a role in the disease process.
The pathways identified included Th1/Th2 immune signaling, Th17 activation, IL-17 signaling, and chemokine pathways—all involved in how the immune system responds to challenges. These pathways are often active when the body encounters threats like viruses or infections.
No Evidence of Specific Infection
One important finding: when researchers looked specifically at virus-related immune pathways, they did not find evidence of infection with any particular pathogen. Instead, the enriched immune pathways in both mothers and newborns pointed to shared inflammatory signaling components that could reflect various exposures or the immune system's general state of readiness.
The analysis identified key immune 'hubs'—central players in immune signaling—including TNF, CD40LG, and multiple chemokines (CCL and CXCL proteins). These molecules are messengers that help coordinate immune responses, but their presence does not point to a single infectious cause.
DNA Methylation Patterns Add Another Layer
Researchers also examined DNA methylation in cord blood—chemical changes to DNA that affect how genes are expressed but do not change the DNA sequence itself. These changes were modest overall, but genes showing differential methylation were associated with immune function and host-pathogen interaction pathways.
The fact that DNA methylation changes aligned biologically with the protein findings suggests that early immune programming—how the body sets up its immune system in the womb and at birth—may be connected to Type 1 diabetes development. This convergence of evidence from different biological measurements strengthens the findings.
What This Means for Understanding Type 1 Diabetes
This research adds to growing evidence that Type 1 diabetes may be rooted in early immune development and inflammatory processes. By identifying immune signatures at birth, scientists are building a map of what healthy and at-risk immune systems look like in newborns.
While these findings are important, they represent early-stage research. Immune signatures alone cannot yet predict who will develop Type 1 diabetes, and these biological markers will need to be validated in other populations before they can be used clinically. The study opens doors for future research into whether modifying these early immune patterns might one day help delay or prevent disease onset.
Evidence label
Source: Cells. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryCauses & What We KnowPregnant Women with Diabetes Show Higher Rates of Toxoplasma InfectionPubMed indexed literature
- Research summaryCauses & What We KnowExploring Rare Breast Inflammation: What BRCA Mutations and Type 1 Diabetes May SharePubMed indexed literature
- Research summaryCauses & What We KnowUnderstanding Type 1 Diabetes: A Shift Toward Early InterventionPubMed indexed literature
- Research summaryCauses & What We KnowHow Nutrition, Metabolism, and Immunity Connect: What the Lectin Pathway Tells UsPubMed indexed literature
- Research summaryCauses & What We KnowHow Gut Bacteria May Influence the Intestinal Barrier in Type 1 DiabetesPubMed indexed literature
- Research summaryCauses & What We KnowLiver Changes in Cystic Fibrosis: What a New Study FoundPubMed indexed literature